vs

Side-by-side financial comparison of Core Laboratories Inc. (CLB) and USA Compression Partners, LP (USAC). Click either name above to swap in a different company.

USA Compression Partners, LP is the larger business by last-quarter revenue ($252.5M vs $121.8M, roughly 2.1× Core Laboratories Inc.). USA Compression Partners, LP runs the higher net margin — 11.0% vs 4.2%, a 6.8% gap on every dollar of revenue. On growth, USA Compression Partners, LP posted the faster year-over-year revenue change (2.7% vs -1.4%). USA Compression Partners, LP produced more free cash flow last quarter ($87.7M vs $517.0K). Over the past eight quarters, USA Compression Partners, LP's revenue compounded faster (4.9% CAGR vs -3.4%).

Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States, diagnostic products, nutritional products, and medical devices.

USA Compression Partners, LP is a US-based provider of natural gas compression services and related infrastructure solutions. It serves clients across the upstream, midstream, and downstream segments of the oil and gas industry, offering custom compression systems, maintenance, and operational support to facilitate efficient natural gas production, processing, and transportation.

CLB vs USAC — Head-to-Head

Bigger by revenue
USAC
USAC
2.1× larger
USAC
$252.5M
$121.8M
CLB
Growing faster (revenue YoY)
USAC
USAC
+4.1% gap
USAC
2.7%
-1.4%
CLB
Higher net margin
USAC
USAC
6.8% more per $
USAC
11.0%
4.2%
CLB
More free cash flow
USAC
USAC
$87.2M more FCF
USAC
$87.7M
$517.0K
CLB
Faster 2-yr revenue CAGR
USAC
USAC
Annualised
USAC
4.9%
-3.4%
CLB

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
CLB
CLB
USAC
USAC
Revenue
$121.8M
$252.5M
Net Profit
$5.1M
$27.8M
Gross Margin
Operating Margin
1.5%
30.3%
Net Margin
4.2%
11.0%
Revenue YoY
-1.4%
2.7%
Net Profit YoY
9.1%
EPS (diluted)
$0.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLB
CLB
USAC
USAC
Q1 26
$121.8M
Q4 25
$138.3M
$252.5M
Q3 25
$134.5M
$250.3M
Q2 25
$130.2M
$250.1M
Q1 25
$123.6M
$245.2M
Q4 24
$129.2M
$245.9M
Q3 24
$134.4M
$240.0M
Q2 24
$130.6M
$235.3M
Net Profit
CLB
CLB
USAC
USAC
Q1 26
$5.1M
Q4 25
$4.9M
$27.8M
Q3 25
$14.2M
$34.5M
Q2 25
$10.6M
$28.6M
Q1 25
$-154.0K
$20.5M
Q4 24
$7.4M
$25.4M
Q3 24
$11.7M
$19.3M
Q2 24
$9.0M
$31.2M
Gross Margin
CLB
CLB
USAC
USAC
Q1 26
Q4 25
20.8%
Q3 25
22.0%
Q2 25
20.3%
Q1 25
19.5%
Q4 24
17.8%
Q3 24
20.5%
Q2 24
21.2%
Operating Margin
CLB
CLB
USAC
USAC
Q1 26
1.5%
Q4 25
11.5%
30.3%
Q3 25
15.6%
33.5%
Q2 25
11.7%
30.6%
Q1 25
3.6%
28.3%
Q4 24
11.0%
30.3%
Q3 24
14.7%
31.5%
Q2 24
12.3%
32.9%
Net Margin
CLB
CLB
USAC
USAC
Q1 26
4.2%
Q4 25
3.6%
11.0%
Q3 25
10.6%
13.8%
Q2 25
8.2%
11.4%
Q1 25
-0.1%
8.4%
Q4 24
5.7%
10.3%
Q3 24
8.7%
8.1%
Q2 24
6.9%
13.3%
EPS (diluted)
CLB
CLB
USAC
USAC
Q1 26
$0.11
Q4 25
$0.11
Q3 25
$0.30
Q2 25
$0.22
Q1 25
$0.00
Q4 24
$0.15
Q3 24
$0.25
Q2 24
$0.19

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLB
CLB
USAC
USAC
Cash + ST InvestmentsLiquidity on hand
$22.8M
$8.6M
Total DebtLower is stronger
$2.5B
Stockholders' EquityBook value
$275.1M
Total Assets
$587.7M
$2.6B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLB
CLB
USAC
USAC
Q1 26
$22.8M
Q4 25
$22.7M
$8.6M
Q3 25
$25.6M
Q2 25
$31.2M
$2.0K
Q1 25
$22.1M
$2.0K
Q4 24
$19.2M
$14.0K
Q3 24
$21.5M
$79.0K
Q2 24
$17.7M
$9.0K
Total Debt
CLB
CLB
USAC
USAC
Q1 26
Q4 25
$110.3M
$2.5B
Q3 25
$114.1M
$2.5B
Q2 25
$124.6M
$2.5B
Q1 25
$124.4M
$2.5B
Q4 24
$126.1M
$2.5B
Q3 24
$139.9M
$2.5B
Q2 24
$147.6M
$2.5B
Stockholders' Equity
CLB
CLB
USAC
USAC
Q1 26
$275.1M
Q4 25
$266.0M
Q3 25
$271.3M
Q2 25
$261.3M
Q1 25
$253.4M
Q4 24
$246.6M
Q3 24
$250.7M
Q2 24
$240.3M
Total Assets
CLB
CLB
USAC
USAC
Q1 26
$587.7M
Q4 25
$584.0M
$2.6B
Q3 25
$591.4M
$2.7B
Q2 25
$602.1M
$2.7B
Q1 25
$591.5M
$2.7B
Q4 24
$585.1M
$2.7B
Q3 24
$600.5M
$2.8B
Q2 24
$597.8M
$2.8B
Debt / Equity
CLB
CLB
USAC
USAC
Q1 26
Q4 25
0.41×
Q3 25
0.42×
Q2 25
0.48×
Q1 25
0.49×
Q4 24
0.51×
Q3 24
0.56×
Q2 24
0.61×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLB
CLB
USAC
USAC
Operating Cash FlowLast quarter
$4.0M
$139.5M
Free Cash FlowOCF − Capex
$517.0K
$87.7M
FCF MarginFCF / Revenue
0.4%
34.8%
Capex IntensityCapex / Revenue
20.5%
Cash ConversionOCF / Net Profit
0.77×
5.02×
TTM Free Cash FlowTrailing 4 quarters
$22.5M
$277.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLB
CLB
USAC
USAC
Q1 26
$4.0M
Q4 25
$7.9M
$139.5M
Q3 25
$8.5M
$75.9M
Q2 25
$13.9M
$124.2M
Q1 25
$6.7M
$54.7M
Q4 24
$20.6M
$130.2M
Q3 24
$13.1M
$48.5M
Q2 24
$17.1M
$96.7M
Free Cash Flow
CLB
CLB
USAC
USAC
Q1 26
$517.0K
Q4 25
$5.0M
$87.7M
Q3 25
$6.5M
$51.9M
Q2 25
$10.4M
$101.1M
Q1 25
$3.9M
$36.3M
Q4 24
$17.4M
$101.2M
Q3 24
$10.4M
$19.8M
Q2 24
$14.3M
$48.2M
FCF Margin
CLB
CLB
USAC
USAC
Q1 26
0.4%
Q4 25
3.6%
34.8%
Q3 25
4.8%
20.7%
Q2 25
8.0%
40.4%
Q1 25
3.1%
14.8%
Q4 24
13.4%
41.1%
Q3 24
7.7%
8.2%
Q2 24
10.9%
20.5%
Capex Intensity
CLB
CLB
USAC
USAC
Q1 26
Q4 25
2.1%
20.5%
Q3 25
1.5%
9.6%
Q2 25
2.7%
9.3%
Q1 25
2.3%
7.5%
Q4 24
2.5%
11.8%
Q3 24
2.0%
12.0%
Q2 24
2.2%
20.6%
Cash Conversion
CLB
CLB
USAC
USAC
Q1 26
0.77×
Q4 25
1.61×
5.02×
Q3 25
0.60×
2.20×
Q2 25
1.31×
4.35×
Q1 25
2.66×
Q4 24
2.78×
5.12×
Q3 24
1.12×
2.51×
Q2 24
1.90×
3.10×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLB
CLB

Segment breakdown not available.

USAC
USAC

Revenue From Contract Operations Excluding Revenue From Related Party$231.7M92%
Entities Affiliated With Energy Transfer LP$16.6M7%
Transferred At Point In Time$5.4M2%

Related Comparisons